Abstract
The alpha-1A adrenergic receptor agonist A61603 reduces cardiac polyunsaturated fatty acid and endocannabinoid metabolites associated with inflammation in vivo
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have